Natera EPS - Earnings per Share 2014-2024 | NTRA
Natera annual and quarterly earnings per share history from 2014 to 2024. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Natera EPS for the quarter ending March 31, 2024 was $-0.56, a 54.47% decline year-over-year.
- Natera EPS for the twelve months ending March 31, 2024 was $-3.11, a 41.87% decline year-over-year.
- Natera 2023 annual EPS was $-3.78, a 32.14% decline from 2022.
- Natera 2022 annual EPS was $-5.57, a 6.91% increase from 2021.
- Natera 2021 annual EPS was $-5.21, a 83.45% increase from 2020.
| Natera Annual EPS | |
|---|---|
| 2023 | $-3.78 |
| 2022 | $-5.57 |
| 2021 | $-5.21 |
| 2020 | $-2.84 |
| 2019 | $-1.79 |
| 2018 | $-2.22 |
| 2017 | $-2.59 |
| 2016 | $-1.95 |
| 2015 | $-2.68 |
| 2014 | $-1.07 |
| 2013 | $-9.66 |
| Natera Quarterly EPS | |
|---|---|
| 2024-03-31 | $-0.56 |
| 2023-12-31 | $-0.63 |
| 2023-09-30 | $-0.95 |
| 2023-06-30 | $-0.97 |
| 2023-03-31 | $-1.23 |
| 2022-12-31 | $-1.37 |
| 2022-09-30 | $-1.25 |
| 2022-06-30 | $-1.50 |
| 2022-03-31 | $-1.45 |
| 2021-12-31 | $-1.52 |
| 2021-09-30 | $-1.63 |
| 2021-06-30 | $-1.32 |
| 2021-03-31 | $-0.74 |
| 2020-12-31 | $-0.92 |
| 2020-09-30 | $-0.72 |
| 2020-06-30 | $-0.75 |
| 2020-03-31 | $-0.45 |
| 2019-12-31 | $-0.44 |
| 2019-09-30 | $-0.33 |
| 2019-06-30 | $-0.48 |
| 2019-03-31 | $-0.54 |
| 2018-12-31 | $-0.50 |
| 2018-09-30 | $-0.49 |
| 2018-06-30 | $-0.62 |
| 2018-03-31 | $-0.61 |
| 2017-12-31 | $-0.87 |
| 2017-09-30 | $-0.52 |
| 2017-06-30 | $-0.55 |
| 2017-03-31 | $-0.65 |
| 2016-12-31 | $-0.82 |
| 2016-09-30 | $-0.50 |
| 2016-06-30 | $-0.46 |
| 2016-03-31 | $-0.17 |
| 2015-12-31 | $3.18 |
| 2015-09-30 | $-0.39 |
| 2015-06-30 | $-3.58 |
| 2015-03-31 | $-1.89 |
| 2014-12-31 | $0.00 |
| 2014-09-30 | $0.03 |
| 2014-06-30 | $-0.11 |
| 2013-12-31 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $13.533B | $1.083B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.299B | 15.60 |
| Cencora (COR) | United States | $46.379B | 18.08 |
| ICON (ICLR) | Ireland | $25.848B | 24.40 |
| DiDi Global (DIDIY) | China | $20.706B | 0.00 |
| Avantor (AVTR) | United States | $14.726B | 21.68 |
| CochLear (CHEOY) | Australia | $13.973B | 0.00 |
| Revvity (RVTY) | United States | $13.407B | 23.52 |
| Medpace Holdings (MEDP) | United States | $12.205B | 40.15 |
| Viatris (VTRS) | United States | $12.109B | 3.62 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.989B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.790B | 20.66 |
| Solventum (SOLV) | United States | $9.423B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $7.951B | 0.00 |
| HealthEquity (HQY) | United States | $7.177B | 46.08 |
| Doximity (DOCS) | United States | $5.537B | 38.78 |
| Bausch + Lomb (BLCO) | Canada | $5.309B | 21.25 |
| Organon (OGN) | United States | $5.246B | 4.98 |
| PACS (PACS) | United States | $4.392B | 0.00 |
| Life Times (LTH) | United States | $3.563B | 37.33 |
| Sotera Health (SHC) | United States | $3.281B | 16.10 |
| GoodRx Holdings (GDRX) | United States | $3.193B | 121.57 |
| Surgery Partners (SGRY) | United States | $3.177B | 29.07 |
| Agilon Health (AGL) | United States | $2.838B | 0.00 |
| Progyny (PGNY) | United States | $2.569B | 44.23 |
| NovoCure (NVCR) | Jersey | $2.296B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.102B | 8.33 |
| Premier (PINC) | United States | $1.927B | 8.24 |
| BrightSpring Health Services (BTSG) | United States | $1.794B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.696B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.591B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.224B | 0.00 | |
| GeneDx Holdings (WGS) | United States | $0.752B | 0.00 |
| CareDx (CDNA) | United States | $0.739B | 0.00 |
| Embecta (EMBC) | United States | $0.738B | 5.02 |
| InnovAge Holding (INNV) | United States | $0.691B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.609B | 6.46 |
| Auna S.A (AUNA) | Luxembourg | $0.600B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 15.27 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.455B | 0.00 |
| Enhabit (EHAB) | United States | $0.441B | 44.00 |
| ModivCare (MODV) | United States | $0.375B | 7.02 |
| Sonida Senior Living (SNDA) | United States | $0.369B | 0.00 |
| LifeMD (LFMD) | United States | $0.329B | 0.00 |
| DocGo (DCGO) | United States | $0.294B | 16.06 |
| Sharecare (SHCR) | United States | $0.292B | 0.00 |
| MultiPlan (MPLN) | United States | $0.281B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.261B | 0.00 |
| Beauty Health (SKIN) | United States | $0.244B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.196B | 0.00 |
| Biodesix (BDSX) | United States | $0.184B | 0.00 |
| So-Young (SY) | China | $0.114B | 55.25 |
| Pono Capital Two (PTWO) | United States | $0.072B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.050B | 0.00 |
| NeueHealth (NEUE) | United States | $0.044B | 5.99 |
| IceCure Medical (ICCM) | Israel | $0.037B | 0.00 |
| Oncology Institute (TOI) | United States | $0.034B | 0.00 |
| Nutex Health (NUTX) | United States | $0.027B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.024B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.024B | 0.00 |
| OncoCyte (OCX) | United States | $0.023B | 0.00 |
| KindlyMD (KDLY) | $0.016B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| DermTech (DMTK) | United States | $0.011B | 0.00 |
| XWELL (XWEL) | United States | $0.011B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
| OpGen (OPGN) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Assure Holdings (IONM) | United States | $0.002B | 0.00 |